Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Factor IX, also known as Christmas factor, is a vitamin K-dependent plasma glycoprotein and a serine protease that plays a crucial role in the intrinsic pathway of blood coagulation. It is synthesized in the liver and circulates in the bloodstream as an inactive zymogen until activated by factor XIa following vascular injury. Mutations or deficiencies in F9 cause hemophilia B—a hereditary bleeding disorder characterized by impaired blood clotting leading to excessive bleeding after injuries or surgery.
Replaces deficient Factor IX, enabling proper blood clot formation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Factor IX (FIX).